Creative Biogene Launches Comprehensive Custom RNA Services to Advance Research and Therapeutic Development

Creative Biogene has announced the release of its custom RNA services, establishing a foundation for transforming scientific discoveries into industry-grade tools and service capabilities. The company, which has focused on RNA delivery technologies for biomolecules including DNA, RNA, and protein for diverse applications, developed these services with a team of experienced scientists in RNA research to meet unprecedented demand for customized RNA solutions.

In the rapidly evolving field of RNA research, RNA has transformed from a research subject into a key element in drug development and therapeutic applications. With continuous emergence of RNA technologies such as mRNA vaccines, circular RNA, and self-amplifying RNA, Creative Biogene's comprehensive customized RNA service provides researchers and developers with tailored solutions that bridge basic research and practical applications. The service offers a complete range of solutions specializing in custom RNA services, including synthesis and customization of mRNA, saRNA, circRNA, and RNA interference molecules.

The company's unique strength lies in rigorous control over quality and consistency, with each batch of RNA products undergoing comprehensive quality control measures to ensure purity and functionality. Researchers can expect batch-to-batch consistency meeting industry standards. The core of Creative Biogene's custom RNA services relies on advanced engineering capabilities enabling sophisticated modifications to RNA to meet diverse application needs. From introducing specific nucleotides to optimizing structural features, each RNA molecule can be finely regulated to enhance stability and efficacy for experimental and clinical uses.

The service offers high flexibility, providing production scales from micrograms to grams to meet needs of both basic research and large-scale therapeutics. The Custom RNA Service provides dedicated support for miRNA and circRNA research, including specialized services such as precise sequence design and expression profiling of miRNAs to elucidate their roles in gene regulation and disease progression. It also includes efficient synthesis and functional analysis of circRNAs to deepen understanding of their dynamic changes and therapeutic potential.

The launch marks the establishment of Creative Biogene's one-stop Contract Development and Manufacturing Organization platform, which integrates all stages of RNA drug development from sequence design and in vitro transcription to GMP-grade manufacturing and validation. CDMO services encompass comprehensive analytical services for assessing RNA integrity and ensuring compliance with stringent regulatory requirements. The introduction of lipid nanoparticle encapsulation technology represents a significant advancement in therapeutic drug delivery, enabling efficient multi-component co-encapsulation to meet diverse therapeutic needs.

Creative Biogene's commitment to becoming a leader in the RNA services market is supported by scientists with extensive expertise in molecular biology, RNA chemistry, and drug development. The company provides researchers with tools needed to translate findings from experimental discoveries into practical applications based on rigorous scientific principles and operational excellence. By providing highly customized RNA solutions, Creative Biogene enhances global research capabilities and drives transformation of innovative ideas into impactful therapies. The company has scale-up expertise and unique mRNA, oligonucleotide and plasmid production capabilities for companies focused on therapeutic, vaccine, diagnostic, and biopharmaceutical breakthroughs through its services available at https://www.creative-biogene.com.